Πλοήγηση ανά Συγγραφέα "Chapple, C."

Αποτελέσματα 1-2 από 2

Comparison of solifenacin 5 MG and tolterodine ER 4 mg in the star OAB study

Chapple, C.; Everaert, K.; Lopatkin, N.; Katona, F.; Melekos, M.; Madsen, H.; Wright, M.; Bolodeoku, J. (2006)
Contemporary Management of Lower Urinary Tract Disease With Botulinum Toxin A: A Systematic Review of Botox (OnabotulinumtoxinA) and Dysport (AbobotulinumtoxinA)

Mangera, A.; Andersson, K. E.; Apostolidis, A.; Chapple, C.; Dasgupta, P.; Giannantoni, A.; Gravas, S.; Madersbacher, S. (2011)

Context: The use of botulinum toxin A (BoNTA) in the treatment of lower urinary tract dysfunction has expanded in recent years and the off-licence usage list includes neurogenic detrusor overactivity (NDO), idiopathic ...